SOHO Brazil 2022

https://rvmais.iweventos.com.br/site/sintoma2022

 

SOHO Brazil 2022
I

SOHO Brazil 2022 on Targeted Therapy in Indolent Lymphomas: The Role of PI3K & Other Inhibitors

By SOHO Brazil 2022 FEATURING Izidore Lossos, Phillip Scheinberg
By SOHO Brazil 2022 FEATURING Izidore Lossos, Phillip Scheinberg
41 views
August 31, 2022
Comments 0
Login to view comments. Click here to Login

Featured Video

11:12
Stemline

A proven CD123 targeted therapy for BPDCN

Feat. H. Erba

Featured Video

16:51
Incyte

Effects of PV Treatment on White Blood Cell Count and Thrombotic Risk

Feat. C. Harrison
Lymphoma
25:36

SOHO Brazil 2022: Are All MZLs the Same? What Do We Know About Subty…

SOHO Brazil 2022

I. Lossos, P. Scheinberg

33 views
27:08

Are We Curing Some Mantle Cell Lymphomas?

SOHO Brazil 2022

J. Chavez, A. Alencar

66 views
23:08

SOHO Brazil 2022 on Bispecifics in Follicular Lymphoma: A “Mini-Revo…

SOHO Brazil 2022

J. Chavez, A. Alencar

20 views
24:15

SOHO Brazil 2022 on CPIs in Hodgkin Lymphoma: Recent Progress

SOHO Brazil 2022

P. Armand, A. Alencar

65 views
24:28

SOHO Brazil 2022 on DLBCL: Finally Breaking the Back of R-CHOP?

SOHO Brazil 2022

C. Moskowitz, A. Alencar

86 views
23:04

SOHO Brazil 2022 on 1st Relapse in DLBCL: Induction Chemo & Autotran…

SOHO Brazil 2022

M. Bishop, P. Scheinberg

13 views
26:04

SOHO Brazil 2022 on Targeted Therapy in Indolent Lymphomas: The Role…

SOHO Brazil 2022

I. Lossos, P. Scheinberg

41 views
32:17

SOHO Brazil 2022 on Waldenstrom’s Macroglobulinemia: The More Diffic…

SOHO Brazil 2022

S. Treon, P. Scheinberg

74 views
27:03

SOHO Brazil 2022: Who Is a Candidate for CAR-T in DLBCL? The Window …

SOHO Brazil 2022

M. Bishop, A. Alencar, P. Scheinberg

16 views
36:30

SOHO Brazil 2022 Discussion: What Are the Options in Primary CNS Lym…

SOHO Brazil 2022

J. Rubenstein, A. Alencar

37 views